TB-500
The body-wide healing shot: looser joints, faster muscle recovery, taken a few times a week. BPC-157's usual partner.
What it is
TB-500 is for the person whose whole body feels beat up: tight hips, a shoulder that never fully loosens, legs that take four days to recover from a hard session. It works everywhere at once, which is exactly what makes it different from BPC-157.
The people who get the most out of TB-500 are the ones with more than one problem at a time. A 45-year-old lifter with a cranky shoulder, a tight lower back and knees that complain on stairs. A runner coming back from a long layoff who is stiff everywhere. Someone a few weeks out of surgery who wants the whole area, not just the incision, to settle. BPC-157 is the one you reach for when a single tendon has hurt for months; TB-500 is the one you reach for when it is the whole machine. It is a lab-made version of thymosin beta-4, a protein your body already uses to move repair cells to damage, and because it travels, you can inject it in the belly fat and let it find the problem.
The first thing most people notice is not healing, it is range of motion. Around week two or three, the morning stiffness eases and a hip or shoulder that always needed ten minutes of warm-up just moves. Recovery between sessions shortens next. Actual tissue repair, a tendon that stops hurting under load, is slower and shows up in weeks four to six if it is going to. What good looks like is quieter joints and a body that bounces back, not a torn ligament knitting itself. It will not fix a full tear, it is not a painkiller, and a sore spot that is purely mechanical (a bad bike fit, a technique problem) stays sore.
People run it in two phases. Loading is 2.5 mg three times a week, which lands you at the 7.5 mg a week ceiling, for four to six weeks. Then maintenance at up to 1 mg two or three times a week while you are still healing, and stop when you are done. TB-500 is not known to lose its effect; the step-down is about not using more than the job needs. It is a 10 mg vial, so loading burns a vial every week and a half; a six-week load is four to five vials, which is the real cost of doing it properly. The classic mistake is running maintenance doses on a real injury and deciding it does nothing. The second mistake is quitting at week two because nothing has happened yet. It does not care about food or time of day, and injecting near the injury is pointless; it is systemic. Expect to feel flat and tired during the first week or two of loading. That passes.
The evidence is heavy on animals and thin on people. In animal work it reliably speeds muscle, skin, cornea and heart tissue repair by pulling repair cells to the damage and growing new small blood vessels. The parent protein, thymosin beta-4, has been in small human wound-healing and dry-eye trials, but TB-500 itself has essentially no human trials, so the thousands of people who swear by it are the human data. Treat it as a strong animal story with real-world use behind it: expect looser joints and a faster bounce-back, not a rebuilt shoulder.
If your problem is one tendon or your gut, skip this and run BPC-157 on its own; it is cheaper and more targeted. If you want both the body-wide effect and the local one, that is the Wolverine stack, BPC-157 + TB-500, and it is what most people with a stubborn injury end up on. Wolverine Plus adds KPV for inflammation if the area is hot and angry. The one group that should sit it out is anyone with a cancer history: TB-500 grows new blood vessels and moves cells around, which is the last thing you want near a tumor.
What people use it for
Muscle and soft tissue recovery
Most evidenceThis is the best-studied use. In animals, TB-500 and its parent protein speed muscle and skin repair by pulling repair cells toward damaged tissue and growing new small blood vessels to feed it. The effect is consistent across many animal models, which is why it has been used in racehorses for years. Humans have not been formally trialed on TB-500 itself, so the field reports are what fill the gap.
Flexibility and stiff joints
Some evidenceThe most common thing people actually report is easier range of motion and less morning stiffness, usually by the second or third week of loading. There is no human trial measuring this, but it lines up with the animal data on tissue remodeling and reduced scar formation. If you only notice one thing from a cycle, this is usually it.
Wounds and skin
Some evidenceThymosin beta-4, the full protein behind TB-500, has been tested in small human trials for slow-healing skin wounds and for dry eye, with modest but real improvements. That is the closest thing to human evidence here, and it is on the parent protein, not on TB-500 as sold.
Heart and nerve tissue
Early daysAnimal studies show thymosin beta-4 helping heart tissue recover after a heart attack and nerves regrow after injury. Interesting, but a long way from anything a person should expect from a cycle. Do not run it for your heart.
How it works
- Animal studies point to faster soft-tissue and wound healing
- Human evidence is very limited, so treat it as promising, not proven
- Works systemically rather than only at the injection site
- Commonly paired with BPC-157 for both whole-body and local repair
How people use it
Safety, in brief
Things people sometimes notice
- Feeling flat or tired during the first week or two of loading
- A dull head pressure for a few hours after a shot
- A small bump or redness where you injected
- Nothing at all for the first two weeks, which is normal
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.
- Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study
- Advances in the basic and clinical applications of thymosin β4
- The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients
- Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart